Tag: Sandostatin

Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program

A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.

With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…

WebMD Articles Raise Awareness about Carcinoid Cancer

Understanding carcinoid tumors, carcinoid syndrome, and treatments for carcinoid when surgery is not an option are the focus of three feature articles by Ellen Greenlaw on WebMD.com this month.  For these articles, Ms. Greenlaw sought the expertise…

Nutrition & Diet Information for Carcinoid Patients: An Interview with Jeffrey I. Mechanick, MD

“Niacin deficiency, general protein energy deficiency, nutrition problems due to surgery, malnutrition and chronic diarrhea, and the excess metabolism of tryptophan,” are the key nutritional issues for carcinoid patients says endocrinologist…

Sandostatin Mobile Administration Program for Carcinoid Syndrome Patients

If you are a carcinoid patient who needs Sandostatin® LAR Depot injections, you may be eligible for the Mobile Administration Program.  This program helps alleviate the stress of driving to a doctor’s office (or finding one where you live or while on vacation),…